Published in Obesity and Diabetes Week, August 7th, 2006
The unique mechanism of action of S-2367 involves blocking receptor binding of neuropeptide Y (NPY), a neurotransmitter involved in regulation of energy balance and food consumption. NPY levels are particularly elevated in reduced weight or food deprived subjects, resulting in stimulation of food intake. S-2367 was designed to counteract elevated NPY levels, thereby promoting weight loss and continued weight loss maintenance.
Shionogi assessed the safety and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.